Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine vs Lamivudine in Decompensated Chronic Hepatitis B
NCT00275652Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2004
- Primary completion
- Aug 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Mayo Clinic. Started Jun 2004; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00275652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275652.